Nasdaq Markets | buzzwords.technology

As Americans have spent weeks staying put at home to slow the spread of COVID-19, the stock market has gone on a wild ride, first crashing and then rallying even as unemployment reached record highs.

The Motley Fool

Here Are My 5 Largest Stock Positions and How They've Performed in 2020

Nasdaq Markets

6 years 4 months ago

The stock market has taken investors on quite a roller-coaster ride in 2020. After reaching all-time highs in February, the S&P 500 and Dow Jones Industrial Average plunged by as much as 40% as the COVID-19 pandemic intensified. Since then, the major indexes have rebounded s

The Motley Fool

Why the FDA's Drug Competition Action Plan Is Bad News for Generic Pharmaceutical Stocks

Nasdaq Markets

6 years 4 months ago

It is no secret that prescription drug prices in America are the highest among all developed nations. A variety of factors have contributed to the issue, such as a lack of universal healthcare coverage, the staggering cost of conducting clinical trials to get drugs to approval,

The Motley Fool

Undervalued Energy Transfer Has Room to Run in 2020

Nasdaq Markets

6 years 4 months ago

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

InvestorPlace

Up 55% in 2020, Is Veeva Systems Stock Still a Buy?

Nasdaq Markets

6 years 4 months ago

Blink and you would have missed Veeva Systems' (NYSE: VEEV) coronavirus slump. The stock is up 55% 2020 to date, driven by continued migration to its cloud-based software for pharmaceutical and biotech companies. The battle to develop treatments for infectious disease and other

The Motley Fool

Medallia Inc (MDLA) Q1 2021 Earnings Call Transcript

Nasdaq Markets

6 years 4 months ago

Image source: The Motley Fool.

The Motley Fool

Why Dollar Tree Should Prosper in Spite of Itself

Nasdaq Markets

6 years 4 months ago

During the pandemic, one might think Dollar Tree (NASDAQ: DLTR) stock would have performed quite well. Its grocery business kept it "essential," and low price points make it affordable to shoppers from any income level.

The Motley Fool

Where Will Regeneron Be in 5 Years?

Nasdaq Markets

6 years 4 months ago

These days, Regeneron (NASDAQ: REGN) seems to be the miracle stock that biotech investors are looking for. Sales of its biologic drug for ocular health, Eylea, and its anti-inflammatory drug, Dupixent, are soaring. Meanwhile, the company is also developing a promising antibody

The Motley Fool

AdvanSix's Shares March Higher, Can It Continue?

Nasdaq Markets

6 years 4 months ago

As of late, it has definitely been a great time to be an investor in AdvanSix Inc. ASIX. The stock has moved higher by 5.8% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the

Zacks

Coeur Mining's Shares March Higher, Can It Continue?

Nasdaq Markets

6 years 4 months ago

As of late, it has definitely been a great time to be an investor in Coeur Mining, Inc. CDE. The stock has moved higher by 42% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that t

Zacks